Solution structure by nuclear magnetic resonance of the two lantibiotics 97518 and NAI-107

Journal of Peptide Science

Volumn 18, Issue 2, 2012, Pages 129-134

  Vasile, Francesca ^a   Potenza, Donatella ^a   Marsiglia, Barbara ^b   Maffioli, Sonia ^c   Donadio, Stefano ^c  

^a UNIVERSITY OF MILAN   (Italy)

^b Merck Serono   (Italy)

^c NAICONS Srl   (Italy)

Author keywords

3D structure; Dynamic simulation; Lantibiotic; Nuclear magnetic resonance

Indexed keywords

LANTIBIOTIC; LANTIBIOTIC 97518; NAI 107; UNCLASSIFIED DRUG;

ARTICLE; DRUG CONFORMATION; MOLECULAR DYNAMICS; NUCLEAR OVERHAUSER EFFECT; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; STRUCTURE ACTIVITY RELATION; THREE DIMENSIONAL IMAGING;

AMINO ACID SEQUENCE; BACTERIOCINS; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR CONFORMATION; MOLECULAR DYNAMICS SIMULATION; MOLECULAR SEQUENCE DATA; PEPTIDES; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; STRUCTURE-ACTIVITY RELATIONSHIP;

MICROBISPORA; PLANOMONOSPORA; POSIBACTERIA;

EID: 84856408214     PISSN: 10752617     EISSN: 10991387     Source Type: Journal    
DOI: 10.1002/psc.1425     Document Type: Article

References (24)

1. Kellner R, Jung G, Horner T, Zähner H, Schnell N, Entian KD, Gotz F. Gallidermin: a new lanthionine-containing polypeptide antibiotic. Eur. J. Biochem. 1988; 177: 53-59.
2. Allgaier H, Jung G, Werner RG, Schneider U, Zähner H. Epidermin: sequencing of a heterodet tetracyclic 21-peptide amide antibiotic. Eur. J. Biochem. 1986; 160: 9-22.
3. McAuliffe O, Ross RP, Hill C. Lantibiotics: structure, biosynthesis and mode of action. FEMS Microb. Rev. 2001; 25: 285-308.
4. Willey JM, van der Donk WA. Lantibiotics: peptides of diverse structure and function. Annu. Rev. Microbiol. 2007; 61: 477-501.
5. Martin NI, Breukink E. Expanding role of lipid II as a target for lantibiotics. Future Microbiol. 2007; 2: 513-525.
6. Jabes D, Brunati C, Candiani G, Riva S, Romano' G, Donadio S. Efficacy of the new lantibiotic NAI-107 in experimental infections induced by MDR Gram positive pathogens. Antimicrob. Agents Chemother. 2011. doi: 10.1128/AAC.01288-10.
7. Chatterjee MP, Xie L, van der Donk WA, Biosynthesis and mode of action of lantibiotics. Chem. Rev. 2005; 105: 633-684.
8. Bonelli RR, Schneider T, Sahl HG, Wiedemann I. Insights into in vivo activities of lantibiotics from gallidermin and epidermin mode-of-action studies. Antimicrob. Agents Chemother. 2006; 50: 1449-1457.
9. Castiglione F, Lazzarini A, Carrano L, Corti E, Ciciliato I, Gastaldo L, Candiani P, Losi D, Marinelli F, Selva E, Parenti F. Determining the structure and mode of action of microbisporicin, a potent lantibiotic active against multiresistant pathogens. Chem. Biol. 2008; 15: 22-31.
10. Castiglione F, Cavaletti L, Losi D, Lazzarini A, Carrano L, Feroggio M, Ciciliato I, Corti E, Candiani G, Marinelli F, Selva E. A novel lantibiotic acting on bacterial cell wall synthesis produced by the uncommon actinomycete Planomonospora sp. Biochemistry 2007; 46: 5884-5895.
11. Maffioli SI, Potenza D, Vasile F, De Matteo M, Sosio M, Marsiglia B, Rizzo V, Scolastico C, Donadio S. Structure revision of the lantibiotic 97518. J. Nat. Prod. 2009; 72(4): 605-607. DOI: 10.1021/np800794y.
12. an den Hooven HW, Fogolari F, Rollema HS, Konings RN, Hilbers CW, van de Ven FJ. NMR and circular dichroism studies of the lantibiotic nisin in non-aqueous environments. FEBS Lett. 1993; 319 (1-2): 189-194.
13. Zimmermann N, Jung G. The three-dimensional solution structure of the lantibiotic murein-biosynthesis-inhibitor actagardine determined by NMR. Eur. J. Biochem. 1997; 246(3): 809-819.
14. Van Den Hooven HW, Doeland CC, Van De Kamp M, Konings RN, Hilbers CW, Van De Ven FJ. Three-dimensional structure of the lantibiotic nisin in the presence of membrane-mimetic micelles of dodecylphosphocholine and of sodium dodecylsulphate. Eur. J. Biochem. 1996; 235(1-2): 382-393.
15. Ekkelenkamp MB, Hanssen M, Danny Hsu ST, de Jong A, Milatovic D, Verhoef J, van Nuland NA. Isolation and structural characterization of epilancin 15X, a novel lantibiotic from a clinical strain of Staphylococcus epidermidis. FEBS Lett. 2005; 579(9): 1917-1922.
16. Bartels C, Xia T, Billeter M, Giintert P, Wuthrich K. The program XEASY for computer-supported NMR spectral analysis of biological molecules. J. Biomol. NMR 1995; 6: l-lO.
17. Wuthrich K. NMR of Proteins and Nucleic Acids. New York (NY), USA: Wiley-Interscience. 1986. ISBN: 0471119172.
18. Guntert P, Mumenthaler C, Wuthrich K. Torsion angle dynamics for NMR structure calculation with the new program DYANA. J. Mol. Biol. 1997; 273: 283-298.
19. Van de Ven FJ, Van den Hooven HW, Konings RN, Hilbers CW. NMR studies of lantibiotics. The structure of nisin in aqueous solution. Eur. J. Biochem. 1991; 202 (3): 1181-1188.
20. van Leeuwenhoek A Structures of lantibiotics studied by NMR. Biomedical and Life Sciences. 1996; 69 (2): 99-107. DOI: 10.1007/BF00399415.
21. Freund S, Jung G, Gutbrod O, Folkers G, Gibbons WA, Allgaier H, Werner R. The solution structure of the lantibiotic gallidermin. Biopolymers 1991; 31(6): 803-811.
22. Smith L, Zachariah C, Thirumoorthy R, Rocca J, Novák J, Hillman JD, Edison AS. Structure and dynamics of the lantibiotic mutacin 1140. Biochemistry 2003; 42: 10372.
23. van De Ven FJM, Jung G, Structures of lantibiotics studied by NMR. Antonie Van Leeuwenhoek, 1996; 69: 99.
24. Kodani S, Hudson ME, Durrant MC, Buttner MJ, Nodwell JR, Willey JM. The SapB morphogen is a lantibiotic-like peptide derived from the product of the decelopmental gene ramS in Streptomyces coelicolor. P.N.A.S. 2004; 101: 11448.